UK Markets close in 2 hrs 11 mins

H&R GmbH & Co. KGaA: Final Nine-months 2022 once again on a high level

EQS-News: H&R GmbH & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results
H&R GmbH & Co. KGaA: Final Nine-months 2022 once again on a high level
15.11.2022 / 11:11 CET/CEST
The issuer is solely responsible for the content of this announcement.

Press Release

H&R GmbH & Co. KGaA: Quarterly Report for third quarter of 2022

  • Operating result (EBITDA) with € 103.3 million again at very good level

  • Full-year result expected at up to € 120.0 million

Salzbergen, Germany, November 15, 2022. H&R GmbH & Co. KGaA (short: H&R KGaA; ISIN DE000A2E4T77) has confirmed its preliminary sales and earnings figures for the third quarter of 2022: From July to September 2022, the company achieved an operating result (EBITDA - consolidated earnings before income taxes, other financial income and expenses as well as amortization, depreciation and impairment losses and write-ups on intangible assets and property, plant and equipment) of EUR 30.5 million (same period of the previous year: EUR 36.8 million). After a moderate start to the year and a very good performance in the middle, the third quarter delivered the second highest contribution to earnings this year. EBIT closed at EUR 17.2 million, down from last year's EUR 24.1 million. Earnings before taxes (EBT) for Q3-2022 were EUR 15.3 million (Q3-2021: EUR 22.6 million), and the company closed at EUR 10.4 million for consolidated net income attributable to shareholders (Q3-2021: EUR 16.0 million). Sales in the third quarter of the current fiscal year increased to EUR 418.7 million (Q3-2021: EUR 319.7 million), mainly due to higher raw material costs compared to the previous year.

Overview of key figures:

in million EUR

Nine months 2022

Nine Months 2021

Diff. abs.

Sales Revenues

1,224.5

878.2

346.3

ChemPharm REFINING

802.7

556.2

246.5

ChemPharm SALES

401.8

299.2

102.6

PLASTICS

3.2

32.4

1.8

Consolidation

-14.2

-9.6

-4.6

 

 

 

 

Operative Earnings (EBITDA)

103.3

113.3

-8.0

ChemPharm REFINING

74.3

89.8

-15.5

ChemPharm SALES

29.6

21.8

7.8

PLASTICS

2.4

2.3

0.1

Consolidation

-3.1

-2.6

-0.5

 

 

 

 

EBIT

63.4

73.2

-9.8

Earnings before Taxes

58.2

67.0

-8.8

Net Income attributable to Shareholders

40.1

47.0

-6.9

Earnings per Share (in EUR)

1.08

1.26

-0.18

Operative Cashflow

-9.0

13.1

-22.1

Free Cashflow

-60.3

-25.5

-34.8

 

 

 

 

 

Q3 2022

Q3 2021

Diff. abs.

Sales Revenues

418.7

319.7

99.0

ChemPharm REFINING

268.4

204.2

64.2

ChemPharm SALES

141.9

108.6

33.3

PLASTICS

13.1

10.9

2.2

Consolidation

-4.7

-3.9

-0.8

 

 

 

 

Operative Earnings (EBITDA)

30.5

36.8

-6.3

ChemPharm REFINING

19.4

30.9

-11.5

ChemPharm SALES

10.9

6.6

4.3

PLASTICS

1.1

0.5

0.6

Consolidation

-0.9

-1.2

0.3

 

 

 

 

EBIT

17.2

24.1

-6.9

Earnings before Taxes

15.3

22.6

-7.3

Net Income attributable to Shareholders

10.4

16.0

-5.6

Earnings per Share (in EUR)

0.28

0.43

-0.15

Operative Cashflow

-7.6

12.0

-19.6

Free Cashflow

-31.6

-1.1

30.5

 

 

 

 

 

30/09/2022

31/12/2021

Diff. abs.

Balance Sheet Total

1,003.2

874.4

128.8

Equity

482.1

408.5

73.6

Equity Ratio (in %, difference in percentage points)

48.1

46.7

1.4

Following the increase in its guidance two weeks ago, the company currently continues to expect to achieve the target of up to EUR 120.0 million.

For further information on the business and earnings development, the company refers to the Quarterly Statement on Q3 2022 published today, which can be downloaded from www.hur.com in the "Investor Relations" section.


Contact information:

H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser

Neuenkirchener Strasse 8, 48499 Salzbergen

Tel.: +49 40 43218-321, Fax: +49 40 43218-390

e-mail: ties.kaiser@hur.com ; www.hur.com

 

H&R GmbH & Co. KGaA:

H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

 

Forward-looking statements and forecasts:

This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.


15.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:

English

Company:

H&R GmbH & Co. KGaA

Neuenkirchener Str. 8

48499 Salzbergen

Germany

Phone:

+49 (0)40 43 218 321

Fax:

+49 (0)40 43 218 390

E-mail:

investor.relations@hur.com

Internet:

www.hur.com

ISIN:

DE000A2E4T77

WKN:

A2E4T7

Listed:

Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1487967


 

End of News

EQS News Service

show this
show this